Clin2
NCT03762395Possibly a fitRecruiting

Study of anti-inflammatory asthma molecules in adults

AsthmaObesity

Part of Hormones & metabolism, Immune system & allergy, Lungs & breathing clinical trials.

This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Be between 18 and 65 years old
  • Have a BMI of 30 or higher
  • Have asthma diagnosed for at least 6 months and meet specific breathing test results
  • Use asthma controller inhalers (inhaled steroid, and possibly others) at a stable dose for at least 3 months
  • Use safe birth control during the study if you could become pregnant and have a negative pregnancy test before joining

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03215836Recruiting
Study obesity and metabolism in adults with asthma

This study looks at how weight and blood-sugar/fat changes in the body may affect the airways in people with asthma. You may be asked to complete breathing tests and possibly an airway procedure (bronchoscopy) to help researchers compare groups.

Aurora, Colorado
NCT06977581Recruiting· Phase 2
study of PF-07275315 for moderate-to-severe asthma

This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.

Mobile, Alabama
NCT06419413Recruiting
Asthma study in Chinese adults to find better treatment matches

This study looks at how asthma affects people in China and tries to find patterns that might help predict which treatments work best. If you have asthma and are between 18 and 75, you may be able to join.

Chengdu, Sichuan
NCT07780643Not yet recruiting· Phase 3
Asthma study for uncontrolled asthma on inhaled steroids

This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.

NCT07746687Not yet recruiting· Phase 2
Study of a new drug for moderate to severe asthma

This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.

NCT03885245Recruiting· Phase 2
L-citrulline supplement for overweight adults with later-onset asthma

This Phase 2 trial tests whether adding L-citrulline can improve asthma control in overweight adults whose asthma started later in life. It compares your asthma symptoms and lung testing results to see if the supplement helps when asthma is already being treated.

Durham, North Carolina

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.